How to Get Trulicity in Missouri: Prescriptions, Telehealth, and Pharmacy Guide

What Is Trulicity and Why Missouri Patients Request It

Dulaglutide is a once-weekly glucagon-like peptide-1 (GLP-1) receptor agonist manufactured by Eli Lilly. The FDA approved it in 2014 for glycemic control in adults with type 2 diabetes, and the label was updated in 2020 to reflect cardiovascular risk reduction data [1]. Missouri prescribers across all major metropolitan areas, including St. Louis, Kansas City, Springfield, and Columbia, have seen sharp increases in GLP-1 prescription volume since 2021.

The drug works by stimulating glucose-dependent insulin secretion, suppressing glucagon, and slowing gastric emptying [2]. Because it is administered once weekly via a prefilled auto-injector pen, adherence rates tend to be higher than with daily injectable therapies. The American Diabetes Association 2024 Standards of Care recommend a GLP-1 receptor agonist as preferred add-on therapy for patients with established atherosclerotic cardiovascular disease or high cardiovascular risk who have not reached glycemic targets on metformin [3].

In the REWIND trial (N=9,901), dulaglutide 1.5 mg once weekly reduced the composite of nonfatal myocardial infarction, nonfatal stroke, and cardiovascular death by 12% compared with placebo over a median 5.4-year follow-up (HR 0.88 to 95% CI 0.79 to 0.99, P=0.026) [4]. That trial enrolled patients with a mean age of 66 years, approximately 69% of whom had no prior cardiovascular event, making REWIND the broadest primary-prevention dataset for any GLP-1 agonist at the time of publication.

Missouri's physician-to-patient ratio in rural counties (fewer than 1 primary care physician per 3,500 residents in many Ozark region counties, per 2023 HRSA data) means telehealth access is not optional for many residents. It is genuinely the primary route to specialist-level prescribing [5].

Who Can Prescribe Trulicity in Missouri

Missouri allows physicians (MD, DO), nurse practitioners, and physician assistants to prescribe Schedule-exempt drugs including dulaglutide, provided the prescriber holds an active Missouri controlled substance registration where applicable and maintains a valid prescriber-patient relationship [6]. Nurse practitioners in Missouri practice under collaborative practice agreements with physicians for certain advanced practice functions, but prescribing GLP-1 agonists does not require a collaborative agreement under current Missouri statute for certified nurse practitioners with full practice authority granted by their certification body.

A prescriber-patient relationship in Missouri can be established via synchronous audiovisual telehealth. Missouri law (RSMo 191.1145) explicitly recognizes telehealth as a valid modality for establishing a new patient relationship, provided the visit meets the same standard of care as an in-person encounter [7]. Audio-only encounters may satisfy the relationship requirement in certain circumstances under Missouri Medicaid rules, but most commercial telehealth platforms use video to ensure documentation quality.

Prescribers must document a confirmed type 2 diabetes diagnosis (ICD-10 code E11.x), review contraindications (personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, and prior serious hypersensitivity to dulaglutide), and assess renal function before issuing the prescription [1].

Required Labs Before Starting Dulaglutide in Missouri

Most Missouri prescribers and telehealth platforms require a specific set of baseline labs before authorizing dulaglutide. These serve both clinical and insurance-documentation purposes.

HbA1c. A value obtained within the prior 3 to 6 months is standard. Values of 7.0% or above on two separate readings, or a single reading of 7.5% or above, satisfy nearly every Missouri commercial plan's prior authorization threshold. The ADA defines an HbA1c target of <7.0% for most non-pregnant adults, meaning patients above that threshold have documented uncontrolled disease [3].

Comprehensive metabolic panel (CMP). Estimated glomerular filtration rate (eGFR) matters because patients with severe renal impairment (eGFR <15 mL/min/1.73 m²) have limited pharmacokinetic data for dulaglutide, and prescribers adjust monitoring accordingly [2]. The FDA label does not contraindicate use in renal impairment but flags the need for caution [1].

Fasting lipid panel. Many Missouri commercial plans require this as part of a cardiovascular risk assessment before approving a GLP-1 agonist.

Thyroid function (TSH). Required by some but not all Missouri plans. Relevant because GLP-1 receptor agonists carry a class boxed warning for thyroid C-cell tumors based on rodent data, and a documented baseline TSH helps rule out pre-existing thyroid pathology [1].

Urine albumin-to-creatinine ratio (UACR). Requested by endocrinologists for patients with suspected or established diabetic nephropathy. Not universally required but increasingly standard in Missouri nephrology-adjacent diabetes management [8].

Labs drawn at any CLIA-certified Missouri laboratory, including Quest, LabCorp, or hospital outpatient labs, satisfy both prescriber and insurance requirements. Telehealth platforms typically accept uploaded lab results dated within 90 days or order labs directly through partnered draw sites.

How to Get a Trulicity Prescription in Missouri: Step-by-Step

Step 1. Confirm your diagnosis is documented. Your prescriber needs a coded type 2 diabetes diagnosis in your medical record. An HbA1c of 6.5% or above on two tests, or a fasting glucose of 126 mg/dL or above on two separate occasions, meets ADA diagnostic criteria [3].

Step 2. Choose your prescriber pathway. Options include your existing primary care physician, an endocrinologist (average new-patient wait in Missouri is 6 to 14 weeks in urban areas and longer in rural counties), or a telehealth platform licensed in Missouri. Telehealth platforms can typically schedule an initial visit within 48 to 72 hours.

Step 3. Gather labs. If you have recent results, upload or bring them. If not, most telehealth platforms can order a lab panel through a national draw-site network; results return within 24 to 48 hours for most standard panels.

Step 4. Complete your visit. The prescriber reviews your history, contraindications, current medications (watch for insulin secretagogues that may require dose adjustment), and goals. If dulaglutide is appropriate, the prescription is sent electronically to your preferred pharmacy.

Step 5. Manage prior authorization if required. If your Missouri commercial insurance requires PA (see section below), your prescriber submits the PA request with your HbA1c, documented metformin trial, and cardiovascular risk data. Most Missouri plans respond within 3 to 5 business days for standard PA and within 72 hours for urgent PA.

Step 6. Pick up or receive your medication. Retail pharmacies dispense the drug within 24 hours of PA approval. Mail-order pharmacies typically ship within 3 to 5 business days. The auto-injector pens require refrigeration at 36 to 46°F (2 to 8°C) during shipping and storage [1].

Telehealth Prescribing for Trulicity in Missouri

Missouri telehealth law permits synchronous audiovisual prescribing for dulaglutide without a prior in-person visit. This is significant for rural Missouri patients in counties like Shannon, Ozark, or Carter, where the nearest endocrinologist may be more than 90 minutes away [5].

A licensed Missouri telehealth provider follows the same clinical standard as an in-person visit: full medical history, contraindication screening, lab review, and informed consent discussion covering the boxed warning for thyroid C-cell tumors [1]. The prescriber must be licensed in Missouri and the patient must be physically located in Missouri at the time of the visit.

Telehealth platforms operating in Missouri include national services that hold Missouri prescriber licenses and state-based services. HealthRX connects Missouri patients with board-certified physicians and nurse practitioners who can evaluate, prescribe, and monitor dulaglutide therapy entirely via video visit.

The HealthRX Missouri access framework for dulaglutide involves three touchpoints: (1) an initial 30-minute video visit for diagnosis review and lab ordering, (2) a 15-minute lab-review visit once results return, and (3) a prescription issuance with electronic routing to the patient's chosen Missouri pharmacy or a mail-order partner. Follow-up visits occur at 4 weeks (dose titration assessment), 12 weeks (HbA1c recheck), and every 6 months thereafter, aligning with ADA monitoring recommendations [3].

Prescriptions issued via telehealth in Missouri carry the same legal weight as those written in person. Missouri pharmacies must fill them without additional verification beyond standard DEA/NPI confirmation.

Prior Authorization Requirements for Trulicity in Missouri

Prior authorization is required by the majority of Missouri commercial insurance plans, including those offered through Anthem BlueCross BlueShield of Missouri, Cigna Missouri, and United HealthCare Missouri [9]. Missouri Medicaid does not cover dulaglutide for type 2 diabetes, so Medicaid beneficiaries must pursue the Lilly Cares patient assistance program or the $35/month Lilly Insulin Value Program equivalent for GLP-1s, or access dulaglutide through a 503A compounding pharmacy.

Standard Missouri commercial PA documentation requirements include:

1. Confirmed type 2 diabetes diagnosis with ICD-10 code
2. HbA1c of 7.0% or above (many plans require 8.0% or above for first-line GLP-1 approval)
3. Documentation of at least 90 days of metformin therapy at maximum tolerated dose (or documented metformin intolerance or contraindication)
4. Prescriber attestation of cardiovascular risk or established ASCVD for plans that require step-through of other agents first
5. Current medication list

The Endocrine Society 2022 clinical practice guideline on type 2 diabetes management states: "For patients with type 2 diabetes and established cardiovascular disease or at high cardiovascular risk, we recommend a GLP-1 receptor agonist with proven cardiovascular benefit." [10]. That language directly supports prior authorization appeals when initial requests are denied.

Appeals succeed at a higher rate when the prescriber includes the REWIND cardiovascular outcomes data and the patient's specific cardiovascular risk factors. Missouri law requires insurers to respond to standard PA requests within 3 business days and to urgent PA requests within 24 hours under the Missouri Health Care Rights Act [11].

Missouri Pharmacy Access: Retail, Mail-Order, and 503A Options

Retail pharmacies. CVS, Walgreens, Walmart Pharmacy, and independent Missouri pharmacies all stock or can order Trulicity. The drug is dispensed in 4-pen cartons (one month supply). Retail cash price without insurance runs approximately $900 to $1,000 per month in Missouri; with the Lilly $35/month savings card (available to commercially insured patients not using federal benefits), out-of-pocket cost drops substantially [12].

Mail-order pharmacies. Most Missouri commercial plans have preferred mail-order pharmacies. Mail-order typically delivers a 90-day supply, which reduces cost per unit and ensures patients do not run out between refills. Trulicity ships refrigerated via overnight or 2-day cold-chain shipping.

503A compounding pharmacies. Missouri-licensed 503A pharmacies can compound dulaglutide for individual patients with a valid prescription. 503A compounding is patient-specific and must be prepared by a state-licensed compounding pharmacy following USP 797 sterile compounding standards [13]. Compounded dulaglutide is not FDA-approved and does not carry the same bioequivalence assurance as the branded auto-injector, but it may provide cost access for patients without insurance coverage.

The FDA has noted that compounded versions of GLP-1 receptor agonists do not have demonstrated safety and efficacy data equivalent to FDA-approved products, and patients should be counseled accordingly [14]. Missouri's State Board of Pharmacy regulates 503A pharmacies and requires them to operate under Missouri pharmacy law, with sterile compounding permitted only in facilities that pass USP 797 inspection.

Titration, Monitoring, and Follow-Up for Missouri Patients

Dulaglutide starts at 0.75 mg once weekly. After 4 weeks, the dose increases to 1.5 mg once weekly if tolerated. The maximum approved dose is 4.5 mg once weekly, reached via stepwise titration at 4-week intervals through 3.0 mg [1]. Gastrointestinal side effects (nausea, vomiting, diarrhea) are most common during the first 4 to 8 weeks and attenuate with time.

In the AWARD-11 trial (N=1,842), dulaglutide 4.5 mg produced a mean HbA1c reduction of 1.87% from a baseline of 8.6%, compared with 1.21% for the 1.5 mg dose at 36 weeks (P<0.001) [15]. Weight loss was 4.7 kg with 4.5 mg versus 2.7 kg with 1.5 mg at 36 weeks [15]. Missouri prescribers managing patients who do not reach HbA1c targets at 1.5 mg should document the titration attempt before requesting higher-dose PA approval.

Monitoring labs recommended by the ADA at each visit interval include: HbA1c every 3 months until stable, then every 6 months; annual CMP for renal and hepatic function; annual fasting lipid panel; and annual UACR in patients with any degree of nephropathy [3]. Missouri telehealth platforms can order these labs at partnered draw sites statewide, with results routed electronically to the prescribing provider [7].

Transferring an Existing Trulicity Prescription to Missouri

Patients relocating to Missouri from another state can transfer their existing Trulicity prescription to a Missouri pharmacy, provided the prescription has remaining refills and was issued by a prescriber licensed in the originating state at the time of writing. Missouri pharmacies accept out-of-state prescriptions for non-controlled substances including dulaglutide under the same rules that govern any non-controlled Rx transfer.

The receiving Missouri pharmacy contacts the originating pharmacy, verifies the prescription details, and dispenses the remaining supply. If the out-of-state prescription has no remaining refills, the patient needs a new prescription from a Missouri-licensed prescriber. A telehealth visit with a Missouri-licensed provider can establish the new prescriber-patient relationship and issue a Missouri-compliant prescription within 48 to 72 hours in most cases.

Patients who used a mail-order pharmacy in their previous state should update their shipping address and confirm the pharmacy is licensed to ship to Missouri. National mail-order pharmacies (including Accredo, Express Scripts, and CVS Specialty) hold Missouri pharmacy licenses and can continue filling existing prescriptions without interruption [16].

Cost and Patient Assistance Programs for Missouri Residents

The Lilly Cares Foundation provides free Trulicity to uninsured and underinsured Missouri patients who meet income eligibility criteria (household income at or below 400% of the federal poverty level for most programs) [12]. Applications are submitted online or by phone; approval typically takes 2 to 4 weeks.

The Lilly $35/month copay savings card applies to commercially insured Missouri patients who are not enrolled in federal health programs (Medicare Part D, Medicaid, TRICARE). The card caps out-of-pocket cost per monthly fill at $35 for eligible patients [12].

GoodRx and similar discount programs list dulaglutide at Missouri pharmacies at prices ranging from $850 to $980 per 4-pen carton (0.75 mg) without insurance. These prices do not stack with manufacturer savings cards but provide an alternative for patients who cannot use the Lilly card.

Missouri residents who qualify for Medicare Part D may find dulaglutide covered under their plan's formulary, though step-therapy requirements (typically requiring prior metformin and often a sulfonylurea or SGLT-2 inhibitor trial) apply under most Part D plans. The $2,000 Medicare Part D out-of-pocket cap implemented in 2025 under the Inflation Reduction Act affects maximum annual exposure for Part D enrollees [17].